Related references
Note: Only part of the references are listed.Soluble Glycoprotein 130 and Heat Shock Protein 27 as Novel Candidate Biomarkers of Chronic Heart Failure with Preserved Ejection Fraction
Shengchen Liu et al.
HEART LUNG AND CIRCULATION (2016)
Circulating Levels of IL-6 Receptor and gp 130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
Vibeke N. Ritschel et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Circulating levels of interleukin 6 soluble receptor and its natural antagonist, sgp130, and the risk of myocardial infarction
Ilais Moreno Velasquez et al.
ATHEROSCLEROSIS (2015)
Blocking IL-6 trans-Signaling Prevents High-Fat Diet-Induced Adipose Tissue Macrophage Recruitment but Does Not Improve Insulin Resistance
Michael J. Kraakman et al.
CELL METABOLISM (2015)
The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition
Christoph Garbers et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN
Michael Luig et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults
Giovanni Zuliani et al.
ATHEROSCLEROSIS (2014)
The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases
Christoph Garbers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Inflammation and Atherosclerosis: A Review of the Role of Interleukin-6 in the Development of Atherosclerosis and the Potential for Targeted Drug Therapy
Joshua Hartman et al.
CARDIOLOGY IN REVIEW (2014)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
The Good, the Bad, and the Ugly of interleukin-6 signaling
Jose J. Fuster et al.
EMBO JOURNAL (2014)
Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain
Iain L. Campbell et al.
JOURNAL OF NEUROSCIENCE (2014)
Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin
Jan Mauer et al.
NATURE IMMUNOLOGY (2014)
IL-6 biology: implications for clinical targeting in rheumatic disease
Leonard H. Calabrese et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
Anna Wonnerth et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Interleukin-6: From basic biology to selective blockade of pro-inflammatory activities
Juergen Scheller et al.
SEMINARS IN IMMUNOLOGY (2014)
Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure Analysis From the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Erik Tandberg Askevold et al.
CIRCULATION-HEART FAILURE (2013)
Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target
Mariangela Allocca et al.
CURRENT DRUG TARGETS (2013)
IL-6 and its receptors in coronary artery disease and acute myocardial infarction
Daniel R. Anderson et al.
CYTOKINE (2013)
IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Judith Hoge et al.
JOURNAL OF IMMUNOLOGY (2013)
Functional IL6R 358Ala Allele Impairs Classical IL-6 Receptor Signaling and Influences Risk of Diverse Inflammatory Diseases
Ricardo C. Ferreira et al.
PLOS GENETICS (2013)
Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Harald Schuett et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Proinflammatory Cytokine Activation Is Linked to Apoptotic Mediator, Soluble Fas Level in Patients With Chronic Heart Failure
Toru Kinugawa et al.
INTERNATIONAL HEART JOURNAL (2012)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
Nadeem Sarwar et al.
LANCET (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model
Tanja Barkhausen et al.
CRITICAL CARE MEDICINE (2011)
The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer
Athena Chalaris et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
Frances Wensley et al.
BRITISH MEDICAL JOURNAL (2011)
Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance
Giovanni Zuliani et al.
ATHEROSCLEROSIS (2010)
Essential Roles of IL-6 Trans-Signaling in Colonic Epithelial Cells, Induced by the IL-6/Soluble-IL-6 Receptor Derived from Lamina Propria Macrophages, on the Development of Colitis-Associated Premalignant Cancer in a Murine Model
Satoshi Matsumoto et al.
JOURNAL OF IMMUNOLOGY (2010)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Paul Elliott et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Correlation of soluble gp130 serum concentrations with arterial blood pressure
Ioana Inta et al.
JOURNAL OF HYPERTENSION (2009)
Genetically elevated C-reactive protein and ischemic vascular disease
Jeppe Zacho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome
Lucia Gottardo et al.
OBESITY (2008)
A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population
Anna Benrick et al.
REGULATORY PEPTIDES (2008)
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
Maren Luchtefeld et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression
M Gwechenberger et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis
B Schieffer et al.
CIRCULATION (2004)
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses
T Jostock et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo
R Atreya et al.
NATURE MEDICINE (2000)
Share Paper
